The Company’s business model is to use its technology platform to provide joined up care across the patient journey. A patient enters DOC’s treatment pathway through a virtual consultation with one of the Company’s GPs. Guided by clinical decision support tools, the GP may organise diagnostic tests through a national network of diagnostic centres, specialist consultant reviews of the results, and provide ongoing clinical management. This may include, where clinically appropriate, facilitating specialist care and intervention.
The global telehealth market is estimated to have been worth US$5.3 billion in 2019 and is forecast to reach US$14.9 billion in 2024, growing at a CAGR of 23.1%. DOC is currently focused on the UK Private Healthcare Market. Healthcare expenditure in the UK exceeded £214 billion and accounted for 10.0% of GDP in 2018, compared with 9.8% in 2017 and 6.9% in 1997. Healthcare spending has more than doubled between 1997 and 2018.
It is anticipated that DOC will list on the ASX during December 2020.
Be the first to comment